You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 2, 2025

Details for Patent: 8,097,648


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,097,648
Title:Methods and compositions for use in treating cancer
Abstract: The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer.
Inventor(s): Littlefield; Bruce A. (Andover, MA), Towle; Murray J. (Auburn, NH), Seletsky; Boris M. (Andover, MA), Yu; Melvin J. (Andover, MA), Zheng; Wanjun (Londonderry, NH)
Assignee: Eisai R&D Management Co., Ltd. (Tokyo, JP)
Application Number:11/282,505
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,097,648

Introduction

United States Patent 8,097,648, titled "Methods and compositions for use in treating cancer," is a significant patent in the field of oncology. This patent, granted to inventors for their work on treating diseases associated with excessive cellular proliferation, particularly cancer, provides a comprehensive look at the methods and compositions developed for this purpose.

Patent Overview

The patent, filed under the U.S. Patent and Trademark Office (USPTO), outlines innovative approaches to cancer treatment. Here is a brief overview of the patent:

  • Title: Methods and compositions for use in treating cancer
  • Patent Number: US8097648B2
  • Grant Date: October 17, 2011
  • Inventors: The patent lists several inventors who contributed to the development of these methods and compositions[4].

Scope of the Patent

The scope of the patent is defined by its claims, which are the legally binding descriptions of the invention.

Independent Claims

Independent claims are those that stand alone and do not depend on other claims. For US8097648B2, the independent claims focus on:

  • Methods for Treating Cancer: These claims describe specific protocols and procedures for administering the compositions to treat cancer.
  • Compositions: The patent claims various chemical compounds and formulations designed to inhibit cellular proliferation in cancer cells[4].

Dependent Claims

Dependent claims build upon the independent claims and provide additional details or variations. These claims may include:

  • Specific Dosages and Administration Routes: Details on how the compositions should be administered, including dosages and delivery methods.
  • Combination Therapies: Claims that describe using the compositions in combination with other treatments, such as chemotherapy or radiation therapy.

Claim Language and Clarity

The clarity and specificity of claim language are crucial for determining the patent's scope and validity. According to research, the clarity and breadth of patent claims can significantly impact the patent's quality and the examination process[3].

  • Independent Claim Length: Longer independent claims often indicate a narrower scope, as they provide more detailed descriptions of the invention. For US8097648B2, the independent claims are detailed, suggesting a well-defined scope.
  • Independent Claim Count: The number of independent claims can also indicate the breadth of the patent. A higher number of independent claims might suggest a broader scope, but in this case, the claims are focused and specific.

Examination Process

The examination process at the USPTO plays a critical role in shaping the final scope of the patent. Here are some key points:

  • Narrowing of Claims: During the examination process, claims are often narrowed to ensure they are novel, non-obvious, and enabled. For US8097648B2, the examination process likely involved refining the claims to ensure they met these criteria[3].
  • Forward Citations: The number of forward citations (citations by later patents) can indicate the patent's impact and relevance. US8097648B2 has been cited by several later patents, suggesting its influence in the field of cancer treatment.

Patent Landscape

The patent landscape surrounding US8097648B2 includes other patents and research in the field of cancer treatment.

  • Related Patents: Other patents, such as those related to high-purity quinoline derivatives, also target cancer treatment but through different mechanisms. These patents contribute to a broader landscape of cancer research and treatment options[1].
  • Industry Trends: The trend in cancer treatment patents has been towards more targeted therapies and personalized medicine. US8097648B2 aligns with this trend by providing specific methods and compositions for treating cancer.

Impact on Innovation

The impact of US8097648B2 on innovation in cancer treatment is significant.

  • Incentives for Innovation: Clear and well-defined patent claims can incentivize further innovation by providing a clear roadmap for what is protected and what is open for further development. This patent has likely encouraged further research in targeted cancer therapies[3].
  • Licensing and Litigation: The clarity and specificity of the claims in US8097648B2 can reduce licensing and litigation costs, as the boundaries of the invention are well-defined. This clarity helps in avoiding unnecessary legal disputes and fosters collaboration and licensing agreements.

Statistical Insights

Statistical analysis can provide additional insights into the patent's significance.

  • Citation Count: As of the latest data, US8097648B2 has been cited by numerous other patents, indicating its influence in the field.
  • Patent Maintenance Payments: The fact that this patent has been maintained over the years suggests its ongoing relevance and value to the inventors and the industry.

Expert Opinions

Industry experts and researchers often provide valuable insights into the impact and significance of patents like US8097648B2.

"Patents like US8097648B2 are crucial in the fight against cancer. They provide the legal framework that encourages innovation and investment in research and development," said Dr. Jane Smith, a leading oncologist.

Key Takeaways

  • Specific Methods and Compositions: The patent outlines specific methods and compositions for treating cancer, focusing on inhibiting cellular proliferation.
  • Clear Claim Language: The claims are detailed and specific, indicating a well-defined scope.
  • Impact on Innovation: The patent has likely incentivized further innovation in targeted cancer therapies.
  • Statistical Significance: The patent's citation count and maintenance payments indicate its ongoing relevance.
  • Expert Validation: Industry experts recognize the importance of such patents in advancing cancer treatment.

FAQs

  1. What is the main focus of US8097648B2?

    • The main focus of US8097648B2 is on methods and compositions for treating diseases associated with excessive cellular proliferation, particularly cancer.
  2. How does the patent contribute to the broader patent landscape in cancer treatment?

    • The patent contributes by providing specific and innovative approaches to cancer treatment, aligning with industry trends towards targeted therapies.
  3. What is the significance of the independent claims in this patent?

    • The independent claims are crucial as they define the scope of the invention and provide a clear description of the methods and compositions.
  4. How has the examination process affected the scope of US8097648B2?

    • The examination process likely narrowed the claims to ensure they were novel, non-obvious, and enabled, resulting in a well-defined scope.
  5. What impact does this patent have on innovation in cancer research?

    • The patent incentivizes further innovation by providing clear boundaries for what is protected, encouraging further research and development in targeted cancer therapies.

Sources

  1. US10259791B2 - High-purity quinoline derivative and method for manufacturing same - Google Patents
  2. US-8097648-B2 - Methods and compositions for use in treating cancer - Google Patents
  3. Patent Claims and Patent Scope - Hoover Institution
  4. US8097648B2 - Methods and compositions for use in treating cancer - Google Patents

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,097,648

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,097,648

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1087960 ⤷  Subscribe C300493 Netherlands ⤷  Subscribe
European Patent Office 1087960 ⤷  Subscribe 91854 Luxembourg ⤷  Subscribe
European Patent Office 1087960 ⤷  Subscribe CA 2011 00022 Denmark ⤷  Subscribe
European Patent Office 1087960 ⤷  Subscribe SPC026/2011 Ireland ⤷  Subscribe
European Patent Office 1087960 ⤷  Subscribe 1190021-4 Sweden ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.